Whanin Pharm Co Ltd
KRX:016580
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Whanin Pharm Co Ltd
Intangible Assets
Whanin Pharm Co Ltd
Intangible Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Intangible Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
W
|
Whanin Pharm Co Ltd
KRX:016580
|
Intangible Assets
₩9.3B
|
CAGR 3-Years
43%
|
CAGR 5-Years
25%
|
CAGR 10-Years
15%
|
|
|
Yuhan Corp
KRX:000100
|
Intangible Assets
₩184.7B
|
CAGR 3-Years
12%
|
CAGR 5-Years
26%
|
CAGR 10-Years
32%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Intangible Assets
₩49.6B
|
CAGR 3-Years
42%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Intangible Assets
₩113.3B
|
CAGR 3-Years
10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
5%
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Intangible Assets
₩126B
|
CAGR 3-Years
18%
|
CAGR 5-Years
34%
|
CAGR 10-Years
39%
|
|
|
C
|
Caregen Co Ltd
KOSDAQ:214370
|
Intangible Assets
₩5.1B
|
CAGR 3-Years
9%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
Whanin Pharm Co Ltd
Glance View
Whan In Pharmaceutical Co., Ltd. engages in the manufacture and sale of medical supplies. The company is headquartered in Seoul, Seoul. is a Korea-based company specialized in the manufacturing of pharmaceutical products. The Company’s products consist of antidepressants, antipsychotics, anxiolytics, hypnotics, antiepileptics, attention-deficit/hyperactivity disorder (ADHD) agents, nootropics, antiparkinson drugs, anti-dementia drugs, gastrointestinal drugs, cardiovascular drugs, immunostimulating agents, antibiotics, multi-vitamins, respiratory drugs, dermatologic drugs, antivirals, anti-diabetic agents and others. The firm also involves in the real estate rental business.
See Also
What is Whanin Pharm Co Ltd's Intangible Assets?
Intangible Assets
9.3B
KRW
Based on the financial report for Dec 31, 2025, Whanin Pharm Co Ltd's Intangible Assets amounts to 9.3B KRW.
What is Whanin Pharm Co Ltd's Intangible Assets growth rate?
Intangible Assets CAGR 10Y
15%
Over the last year, the Intangible Assets growth was 30%. The average annual Intangible Assets growth rates for Whanin Pharm Co Ltd have been 43% over the past three years , 25% over the past five years , and 15% over the past ten years .
